Clinical phenotypes and natural progression for motor neuron disease: Analysis from an Australian database

References

• Anonymous. The Scottish Motor Neuron Disease Register: a prospective study of adult onset motor neuron disease in Scotland. Methodology, demography and clinical features of incident cases in 1989 Journal of Neurology, Neurosurgery & Psychiatry. 1992;55:536–41.
   PubMed Web of Science ®Google Scholar
• Kasarkis EJ, Dominic K, Oddone EZ. The National Registry of Veterans with Amyotrophic Lateral Sclerosis: Department of Veterans Affairs Cooperative Studies Program (CSP) 500a. Amyotroph Lateral Scler Other Motor Neuron Disord. 2004; 5(Suppl 1)129–32
   PubMed Web of Science ®Google Scholar
• Miller RG, Anderson FA, Jr, Bradley WG, Brooks BR, Mitsumoto H, Munsat TL, et al. The ALS patient care database: goals, design, and early results. ALS C.A.R.E. Study Group. Neurology. 2000; 54: 53–7
   PubMed Web of Science ®Google Scholar
• Millul A, Beghi E, Logroscino G, Micheli A, Vitelli E, Zardi A. Survival of patients with amyotrophic lateral sclerosis in a population-based registry. Neuroepidemiology. 2005; 25: 114–9
   PubMed Web of Science ®Google Scholar
• Traynor BJ, Codd MB, Corr B, Forde C, Frost E, Hardiman O. Incidence and prevalence of ALS in Ireland, 1995–1997: a population-based study. Neurology 1999; 52: 504–9
   PubMed Web of Science ®Google Scholar
• Anonymous. World Federation of Neurology Research Group on Neuromuscular Diseases Subcommittee on Motor Neuron Disease. Airlie House guidelines. Therapeutic trials in amyotrophic lateral sclerosis. Airlie House ‘Therapeutic Trials in ALS’ Workshop Contributors. Journal of the Neurological Sciences. 1995;129 Suppl:1–10.
   Google Scholar
• Brooks BR. El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial'Clinical limits of amyotrophic lateral sclerosis’ workshop contributors (see comment). Journal of the Neurological Sciences 1994; 124(Suppl)96–107
   PubMed Web of Science ®Google Scholar
• Miller RG, Munsat TL, Swash M, Brooks BR. Consensus guidelines for the design and implementation of clinical trials in ALS. World Federation of Neurology Committee on Research. Journal of the Neurological Sciences. 1999; 169: 2–12
   PubMed Web of Science ®Google Scholar
• Haverkamp LJ, Appel V, Appel SH. Natural history of amyotrophic lateral sclerosis in a database population. Validation of a scoring system and a model for survival prediction. Brain. 1995; 118: 707–19
   PubMed Web of Science ®Google Scholar
• Appel V, Stewart SS, Smith G, Appel SH. A rating scale for amyotrophic lateral sclerosis: description and preliminary experience. Annals of Neurology. 1987; 22: 328–33
   PubMed Web of Science ®Google Scholar
• Talman P, Reid C, Mathers S. The Motor Neuron Disease Handbook: MJA Books 2007.
   Google Scholar
• Gordon PH, Cheng B, Katz IB, Pinto M, Hays AP, Mitsumoto H, et al. The natural history of primary lateral sclerosis (see comment). Neurology. 2006; 66: 647–53
   PubMed Web of Science ®Google Scholar
• Pringle CE, Hudson AJ, Munoz DG, Kiernan JA, Brown WF, Ebers GC. Primary lateral sclerosis: clinical features, neuropathology and diagnostic criteria. Brain. 1992; 115: 495–520
   PubMed Web of Science ®Google Scholar
• Singer MA, Statland JM, Wolfe GI, Barohn RJ. Primary lateral sclerosis. Muscle & Nerve. 2007; 35: 291–302
   PubMed Web of Science ®Google Scholar
• Singer J, Willett J. Applied Longitudinal Data Analysis: Modelling Change and Event Occurrence. Oxford University Press, New York 2003
   Google Scholar
• Collett D. Modelling Survival Data in Medical Research2nd edn. Chapman and Hall, London 2003
   Google Scholar
• Brooks BR, Miller RG, Swash M, Munsat TL, World Federation of Neurology Research Group on Motor Neuron D. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;1:293–9.
   PubMed Web of Science ®Google Scholar
• Leigh PN, Swash M, Iwasaki Y, Ludolph A, Meininger V, Miller RG, et al. Amyotrophic lateral sclerosis: a consensus viewpoint on designing and implementing a clinical trial. Amyotrophic Lateral Scler Other Motor Neuron Disord. 2004; 5: 84–98
   PubMed Web of Science ®Google Scholar
• Eisen A, Weber M. The motor cortex and amyotrophic lateral sclerosis. Muscle & Nerve. 2001; 24: 564–73
   PubMed Web of Science ®Google Scholar
• Ravits J, Laurie P, Fan Y, Moore DH. Implications of ALS focality: rostral-caudal distribution of lower motor neuron loss post mortem. Neurology. 2007; 68: 1576–82
   PubMed Web of Science ®Google Scholar
• Ravits J, Paul P, Jorg C. Focality of upper and lower motor neuron degeneration at the clinical onset of ALS. Neurology. 2007; 68: 1571–5
   PubMed Web of Science ®Google Scholar
• Rosenfeld J, Swash M. What's in a name? Lumping or splitting ALS, PLS, PMA, and the other motor neuron diseases (comment). Neurology. 2006; 66: 624–5
   PubMed Web of Science ®Google Scholar
• Shaw PJ. Molecular and cellular pathways of neurodegeneration in motor neuron disease. Journal of Neurology. Neurosurgery & Psychiatry. 2005; 76: 1046–57
   PubMed Web of Science ®Google Scholar